SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Accelera Innovations Inc (OTCMKTS:ACNV) was a massive decliner during Monday’s trading session. The stock collapsed by close to 50% on high volumes, which were 3 times the daily average. The stock has been unable to move above the psychological resistance level of $0.50 and has seen bears use the lack of buying interest as a selling opportunity. The stock currently trades above its 50 day moving average. The MACD oscillator is on the verge of giving a sell signal indicative of the shift of momentum towards the sell side. Traders can see the stock heading to levels of $0.07 in the near term.

Accelera Innovations Inc (OTCMKTS:ACNV) announced that it had launched a fully working investment relations firm named Yes International. As per the reports, Yes International will work towards improving Accelera’s communication with its shareholders.

Insights of The Matter

The one person who helped Accelera to come up with a full-fledged firm to handle communication vertical is Richard Kaiser. He comes with a whopping 24 years of experience in handling PRs and investors relations for leading public companies. Accelera looks forward to becoming a leader in the healthcare industry, and this partnership will help it doing so in the least possible time.

Accelera intends to stay ahead of shareholders requirements, and Yes International will further pave the way to continue doing the same in the future as well. Yes, International is known for handling investors relations, shareholders presentations and coordination of different meetings and events.

The senior management team of Accelera Innovations is delighted to announce this update and hopes that it will enhance the overall service quality and strengthen the bond between the company and its shareholders.

The prime focus of Accelera is on improving the outcomes of long-term care and post-acute patients. It keeps taking different initiatives to strengthen the communication with shareholders.

Accelera Innovations Continues Inching Higher

Meanwhile, Accelera announced that its wholly-owned subsidiary Advance Life, Inc., continued growing in the healthcare field, ensuring that Accelera kept its market leadership position secured. Under the sound leadership of industry veteran Mr. Jimmy Lacaba, Advance Life continues to show growth throughout Chicagoland area. The revenues earned by the company during the past six months have almost doubled than the revenues generated in the previous six-month period.

The senior management team of the company is confident that these revenues will continue to grow in the coming months as well. Further updates about different steps taken by the company to grow its business and market leadership position will be shared with investors at a later date.